SEARCH

SEARCH BY CITATION

References

  • Arden, B., Clark, S.P., Kabelitz, D. & Mak, T.W. (1995) Human T-cell receptor variable gene segment families. Immunogenetics, 42, 455500.
  • Bar, B.M.A.M., Schattenberg, A., Mensink, E.J.B.M., Geurts van Kessel, A., Smetsers, T.F.C.M., Knops, G.H.J.N., Linders, E.H.P. & De Witte, T. (1993) Donor leukocyte infusions for chronic myeloid leukemia relapsed after allogeneic bone marrow transplantation. Journal of Clinical Oncology, 11, 513519.
  • Bertz, H., Burger, J.A., Kunzmann, R., Mertelsmann, R. & Finke, J. (1997) Adoptive immunotherapy for relapsed multiple myeloma after allogeneic bone marrow transplantation (BMT): evidence for a graft-versus-myeloma effect. Leukemia, 11, 281283.
  • Brichard, V., Van Pel, A., Wolfel, T., Wolfel, C., De Plaen, E., Lethe, B., Coulie, P. & Boon, T. (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. Journal of Experimental Medicine, 178, 489495.
  • De Bueger, M., Bakker, A., Van Rood, J.J., Van Der Woude, F. & Goulmy, E. (1992) Tissue distribution of human minor histocompatibility antigens. Ubiquitous versus restricted tissue distribution indicates heterogeneity among human CTL defined non-MHC antigens. Journal of Immunology, 149, 1788.
  • Dolstra, H., Fredrix, H., Preijers, F., Goulmy, E., Figdor, C.G., De Witte, T. & Van De Wiel-van Kemenade, E. (1997) Recognition of a B cell leukemia-associated minor histocompatibility antigen by CTL. Journal of Immunology, 158, 560.
  • Drobyski, W.R., Keever, C.A., Roth, M.S., Koethe, S., Hanson, G., McFadden, P., Gottschall, J.L., Ash, R.C., Van Tuinen, P., Horowitz, M.M. & Flomenberg, N. (1998a) Salvage immunotherapy using donor leukocyte infusions as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation: efficacy and toxicity of a defined T-cell dose. Blood, 82, 23102318.
  • Drobyski, W.R., Roth, M.S., Thibodeau, S.N. & Gottschall, J.L. (1998b) Molecular remission occurring after donor leukocyte infusions for the treatment of relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation. Bone Marrow Transplantation, 10, 301304.
  • Faber, L.M., Van Der Hoeven, J., Goulmy, E., Hooftman-den Otter, A.L., Luxemburg-Heijs, S.A., Willemze, R. & Falkenburg, J.H. (1995a) Recognition of clonogenic leukemic cells, remission bone marrow and HLA-identical donor bone marrow by CD8+ or CD4+ minor histocompatibility antigen-specific cytotoxic T lymphocytes. Journal of Clinical Investigations, 96, 877883 .
  • Faber, L.M., Van Luxemburg-Heijs, S.A.P., Veenhof. W.F.J., Willemze, R. & Falkenburg, J.H.F. (1995b) Generation of CD4+ cytotoxic T-lymphocyte clones from a patient with severe graft-versus-host disease after allogeneic bone marrow transplantation: implications for graft-versus-leukemia reactivity. Blood, 86, 28212828.
  • Falkenburg, J.H.F., Goselink, H.M., Van Der Harst, D., Van Luxemburg-Heijs, S.A.P., Kooij-Winkelaar, Y.M.C., Faber, L.M., De Kroon, J., Brand, A., Fibbe, W.E., Willemze, R. & Goulmy, E. (1991) Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes. Journal of Experimental Medicine, 174, 2733.
  • Falkenburg, J.H., Wafelman, A.R., Joosten, P., Smit, W.M., Van Bergen, C.A., Bongaerts, R., Lurvink, E., Van Der Hoorn, M., Kluck, P., Landegent, J.E., Kluin-Nelemans, H.C., Fibbe, W.E. & Willemze, R. (1999) Complete remission of accelerated phase chronic myeloid leukemia by treatment with leukemia-reactive cytotoxic T lymphocytes. Blood, 94, 12011208.
  • Ferster, A., Bujan, W., Mouraux, T., Devalck, C., Heimann, P. & Sariban, E. (1994) Complete remission following donor leukocyte infusion in ALL relapsing after haploidentical bone marrow transplantation. Bone Marrow Transplantation, 14, 331332.
  • Fontaine, P., Roy-Proulx, G., Knafo, L., Baron, C., Roy, D.C. & Perreault, C. (2001) Adoptive transfer of minor histocompatibility antigen-specific T lymphocytes eradicates leukemia cells without causing graft-versus-host disease. Nature Medicine, 7, 789794.
  • Giralt, S., Estey, E., Albitar, M., Van Besien, K., Rondon, G., Anderlini, P., O'Brien, S., Khouri, I., Gajewski, J., Mehra, R., Claxton, D., Andersson, B., Beran, M., Przepiorka, D., Koller, C., Kornblau, S., Korbling, M., Keating, M., Kantarjian, H. & Champlin, R. (1997) Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy. Blood, 89, 45314536.
  • Goulmy, E. (1997) Human minor histocompatibility antigens: new concepts for marrow transplantation and adoptive immunotherapy. Immunological Reviews, 157, 125140.
  • Guilloux, Y., Lucas, S., Brichard, V.G., Van Pel, A., Viret, C., De Plaen, E., Brasseur, F., Lethe, B., Jotereau, F. & Boon, T. (1996) A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the N-acetylglucosaminyltransferase V gene. Journal of Experimental Medicine, 183, 11731183 .
  • Den Haan, J.M.M., Sherman, N.E., Blokland, E., Huczko, E., Koning, F., Drijfhout, J.W., Skipper, J., Shabanowitz, J., Hunt, D.F., Engelhard, V.H. & Goulmy, E. (1995) Identification of a graft versus host disease-associated human minor histocompatibility antigen. Science, 268, 14761480.
  • Den Haan, J.M.M., Meadows, L.R., Wang, W., Pool, J., Blokland, E., Bishop, T.L., Reinhardus, C., Shabanowitz, J., Offringa, R., Hunt, D.F., Engelhard, V.H. & Goulmy, E. (1998) The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science, 279, 10541057.
  • Van Der Harst, D., Goulmy, E., Falkenburg, J.H.F., Kooij-Winkelaar, Y.M.C., Van Luxemburg-Heijs, S.A.P., Goselink, H.M. & Brand, A. (1998) Recognition of minor histocompatibility antigens on lymphocytic and myeloid leukemic cells by cytotoxic T-cell clones. Blood, 83, 10601066.
  • Jiang, Y.-Z., Cullis, J.O., Kanfer, E.J., Goldman, J.M. & Barret, A.J. (1998) T cell and NK cell mediated graft-versus-leukaemia reactivity following donor buffy coat transfusion to treat relapse after marrow transplantation for chronic myeloid leukaemia. Bone Marrow Transplantation, 11, 113138.
  • Khouri, I.F., Keating, M., Korbling, M., Przepiorka, D., Anderlini, P., O'Brien, S., Giralt, S., Ippoliti, C., Von Wolff, B., Gajewski, J., Donato, M., Claxton, D., Ueno, N., Andersson, B., Gee, A. & Champlin, R. (1998) Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies. Journal of Clinical Oncology, 16, 28172824.
  • Kolb, H.J., Mittermuller, J., Clemm, C., Holler, E., Ledderose, G., Brehm, G., Heim, M. & Wilmanns, W. (1990) Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood, 76, 24622465.
  • Kolb, H.-J., Schattenberg, A., Goldman, J.M., Hertenstein, B., Jacobsen, N., Arcese, W., Ljungman, P., Ferrant, A., Verdonck, L., Niederwieser, D., Van Rhee, F., Mittermueller, J., De Witte, T., Holler, E. & Ansari, H. (1995) Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. Blood, 86, 20412050.
  • Korngold, R. & Wettstein, P.J. (1990) Immunodominace in the graft-vs-host disease T cell response to minor histocompatibility antigens. Journal of Immunology, 145, 4079.
  • Leber, B., Walker, I.R., Rodriguez, A., McBride, J.A., Carter, R. & Brain, M.C. (1998) Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial cytopenia and late dermatomyositis. Bone Marrow Transplantation, 12, 407.
  • Leemhuis, T., Leibowitz, D., Cox, G., Silver, R., Srour, E.F., Tricot, G. & Hoffman, R. (1993) Identification of BCR/ABL-negative primitive hematopoietic progenitor cells within chronic myeloid leukemia marrow. Blood, 81, 801807.
  • Lokhorst, H.M., Schattenberg, A., Cornelissen, J.J., Thomas, L.L.M. & Verdonck, L. (1997) Donor leukocyte infusions are effective in relapsed multiple myeloma after allogeneic bone marrow transplantation. Blood, 90, 42064211.
  • Mackinnon, S., Papadopoulos, E.B., Carabasi, M.H., Reich, L., Collins, N.H., Boulad, F., Castro-Malaspina, H., Childs, B.H., Gillio, A.P., Kernan, N.A., Small, T.N., Young, J.W. & O'Reilly, R.J. (1998) Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease. Blood, 86, 12611268 .
  • McSweeney, P.A., Niederwieser, D., Shizuru, J.A., Sandmaier, B.M., Molina, A.J., Maloney, D.G., Chauncey, T.R., Gooley, T.A., Hegenbart, U., Nash, R.A., Radich, J., Wagner, J.L., Minor, S., Appelbaum, F.R., Bensinger, W.I., Bryant, E., Flowers, M.E.D., Georges, G.E., Grumet, F.C., Kiem, H.P. & Torok-Storb, B., Yu, C., Blume, K.G. & Storb, R.F. (2001) Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood, 97, 33903400.
  • Mandruzzato, S., Brasseur, F., Andry, G., Boon, T. & Van Der Bruggen, P. (1998) A CASP-8 mutation recognized by cytolytic T lymphocytes on a human head and neck carcinoma. Journal of Experimental Medicine, 186, 785793.
  • Moore, S., Haylock, D.N., Levesque, J.P., McDiarmid, L.A., Samels, L.M., To, L.B., Simmons, P.J. & Hughes, T.P. (1998) Stem cell factor as a single agent induces selective proliferation of the Philadelphia chromosome positive fraction of chronic myeloid leukemia CD34(+) cells. Blood, 92, 24612470.
  • Mutis, T., Schrama, E., Luxemburg-Heijs, S.A., Falkenburg, J.H., Melief, C.J. & Goulmy, E. (1997) HLA class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells. Blood, 90, 10831090.
  • Mutis, T., Schrama, E., Melief, C.J.M. & Goulmy, E. (1998a) CD80-transfected acute myeloid leukemia cells induce primary allogeneic T-cell responses directed at patient specific minor histocompatibility antigens and leukemia-associated antigens. Blood, 92, 16771684.
  • Mutis, T., Schrama, E., Van Luxemburg-Heijs, S.A.P., Falkenburg, J.H.F., Melief, C.J.M. & Goulmy, E. (1998b) HLA Class II restricted T-cell reactivity to a developmentally regulated antigen shared by leukemic cells and CD34+ early progenitor cells. Blood, 90, 10831090.
  • Porter, D.L., Roth, M.S., McGarigle, C., Ferrara, J.L.M. & Antin, J.H. (1994) Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia. New England Journal of Medicine, 330, 100106.
  • Van Rhee, F., Lin, F., Cullis, J.O., Spencer, A., Cross, N.C.P., Chase, A., Bungey, J., Barrett, J. & Goldman, J.M. (1998) Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: the case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood, 83, 33773383.
  • Serody, J.S., Brecher, M.E., Dent, G., Bentley, S.A., Frelinger, J.A. & Shea, T.C. (1997) A method for the production of CD4+ chronic myelogenous leukemia-specific allogeneic T lymphocytes. Cancer Research, 57, 15471553.
  • Serrano, J., Roman, J., Herrera, C., Castillejo, J.A., Navarro, J.A., Reina, M.L., Gonzalez, M.G., Rodriguez, M.C., Pascual, A., Sanchez, J. & Torres, A. (1999) Increasing mixed haematopoietic chimaerism after BMT with total depletion of CD4+ and partial depletion of CD8+ lymphocytes is associated with a higher incidence of relapse. Bone Marrow Transplantation, 23, 475482.
  • Simpson, E., Roopenian, D. & Goulmy, E. (1998) Much ado about minor histocompatibility antigens. Immunology Today, 19, 108112.
  • Slavin, S., Nagler, A., Naparstek, E., Kapelushnik, Y., Aker, M., Cividalli, G., Varadi, G., Kirschbaum, M., Ackerstein, A., Samuel, S., Amar, A., Brautbar, C., Ben Tal, O., Eldor, A. & Or, R. (1998) Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases. Blood, 91, 756763.
  • Smit, W.M., Rijnbeek, M., Van Bergen, C.A., Fibbe, W.E., Willemze, R. & Falkenburg, J.H. (1998) T cells recognizing leukemic CD34(+) progenitor cells mediate the antileukemic effect of donor lymphocyte infusions for relapsed chronic myeloid leukemia after allogeneic stem cell transplantation. Proceedings of the National Academy of Sciences of the United States of America, 95, 1015210157.
  • Szer, J., Grigg, A.P., Philips, G.L. & Sheridan, W.P. (1998) Donor leukocyte infusions after chemotherapy for patients relapsing with acute leukaemia following allogeneic BMT. Bone Marrow Transplantation, 11, 109111.
  • Tekolf, W.A. & Shaw, S. (1984) Primary in vitro generation of cytotoxic cells specific for human minor histocompatibility antigens between HLA-identical siblings. Journal of Immnology, 132, 1756.
  • Theobald, M. (1998) Allorecognition and graft-versus-host disease. Bone Marrow Transplantation, 15, 489498.
  • Toyonaga, B., Yoshikai, Y., Vadasz, V., Chin, B. & Mak, T.W. (1985) Organization and sequences of the diversity, joining, and constant region genes of the human T-cell receptor beta chain. Proceedings of the National Academy of Sciences, 82, 86248628.
  • Tricot, G., Vesole, D.H., Jagganath, S., Hilton, J., Munshi, N. & Barlogie, B. (1996) Graft-versus-myeloma effect: proof of principle. Blood, 87, 11961198.
  • Verdonck, L., Lokhorst, H.M., Dekker, A.W., Nieuwenhuis, H.K. & Petersen, E.J. (1996) Graft-versus-myeloma effect in two cases. Lancet, 347, 800801.
  • Verfaillie, C.M., Miller, W.J., Boylan, K. & McGlave, P.B. (1992) Selection of benign primitive hematopoietic progenitors in chronic myelogenous leukemia on the basis of HLA-DR antigen expression. Blood, 79, 10031010.
  • Vogt, M.H., De Paus, R.A., Voogt, P.J., Willemze, R. & Falkenburg, J.H. (2000a) DFFRY codes for a new human male-specific minor transplantation antigen involved in bone marrow graft rejection. Blood, 95, 11001105.
  • Vogt, M.H., Goulmy, E., Kloosterboer, F.M., Blokland, E., De Paus, R.A., Willemze, R. & Falkenburg, J.H. (2000b) UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition. Blood, 96, 31263132.
  • Wallny, H.J. & Rammensee, H.G. (1990) Identification of classical minor histocompatibility antigen as cell-derived peptide. Nature, 343, 275.
  • Wang, W., Meadows, L.R., Den Haan, J.M.M., Sherman, N.E., Chen, Y., Blokland, E., Shabanowitz, J., Agulnik, A.I., Hebdrickson, R.C., Bishop, C.E., Hunt, D.F., Goulmy, E. & Engelhard, V.H. (1995) Human H-Y: a male specific histocompatibility antigen derived from the SMCY protein. Science, 269, 15881590.
  • Warren, E.H., Greenberg, P.D. & Riddell, S.R. (1998) Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution. Blood, 91, 21972207.